Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

GE Healthcare Expands Shanghai Fast Trak Training Center

Published: Monday, September 24, 2012
Last Updated: Monday, September 24, 2012
Bookmark and Share
Expansion adds IN Cell, Biacore and DeltaVision technologies for drug discovery and development.

GE Healthcare has announced the official opening of its expanded Fast Trak Training Center in Shanghai, China.

The opening ceremony was hosted by Kieran Murphy, CEO of GE Healthcare Life Sciences, and was attended by leading representatives from academia and the local biopharmaceutical and biotechnology industry.

GE Healthcare’s Fast Trak Training and Education Courses provide hands-on practical training in the latest technologies and strategies for start-to-finish bioprocessing, and are specifically designed to help manufacturers of biopharmaceuticals increase their process productivity and bring their product to market faster.

The company’s Fast Trak Training Centers, which are also located in Germany, India, Japan, Singapore, and the US, are equipped with the latest technologies for bioprocessing, in an environment that closely replicates the industrial setting.

GE Healthcare’s Fast Trak Training & Education team has over 20 years’ experience in providing training for bioprocess development and manufacturing.

By expanding the Fast Trak Center in Shanghai, GE Healthcare will be able to offer an increased number and variety of courses to meet the needs of the rapidly growing biopharmaceutical industry in China.

The extended Center has been equipped with several new GE Healthcare technologies such as IN Cell and DeltaVision™ for cellular imaging and Biacore™ and Microcal™ tools for protein interaction studies, allowing the company to offer, for the first time, training in some of the latest techniques used in drug discovery and development.

In addition to training, the Shanghai Fast Trak Center will also offer a full bioprocess development service to the industry, helping manufacturing professionals develop, optimize and refine their biopharmaceutical manufacturing processes for maximum productivity.

At the opening ceremony Mr Murphy also outlined GE Healthcare’s plans to launch an Educational Outreach Program for local university science students, in order to stimulate and encourage interest in the biopharmaceutical manufacturing industry.

Called Biotech “Future Stars” Training Program, the Outreach Program will be based on standard Fast Trak training courses and will be delivered by GE Healthcare scientists and sector experts.

Mr Murphy said, “I’m delighted to be opening our upgraded and expanded training facility here today. Bigger and better facilities will help us to offer a much higher level of support to the biopharmaceutical industry here in China. The Chinese government has identified the development of the biopharmaceutical industry as one of the pillar industries in the country’s 12th 5 year plan of state, and our new investments here in Shanghai are aligned with that.”

The Fast Trak Center is located within the GE China Technology Center (CTC), an integrated multi-disciplinary research campus with more than 1,500 researchers in over 60 laboratories researching breakthrough technologies in key areas such as energy, materials science and imaging technologies.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

GE Healthcare Life Sciences and Promosome Sign Licensing Agreement
Innovative mammalian cell line development technologies that show promise for increasing manufacturing efficiency of vital biopharmaceuticals.
Tuesday, April 29, 2014
GE Acquires Strategic Assets from Thermo
GE to acquire cell culture media and sera, gene modulation and magnetic beads businesses.
Monday, January 06, 2014
GE Healthcare Launches Modular Biopharmaceutical Factory, KUBio
Innovative approach will save biopharmaceutical manufacturers time and money.
Tuesday, January 15, 2013
iBio, Inc. and GE Healthcare Form New Global Alliance
Companies to commercialize plant-based technologies for biopharmaceutical and vaccine manufacture.
Thursday, December 27, 2012
GE Healthcare Offers Fast Trak Training in Singapore
Fast Trak training and education courses provide practical training in the latest technologies and strategies for bioprocessing.
Tuesday, June 05, 2012
Karolinska University Hospital and GE Healthcare Collaborate to Advance Technologies for Cell Therapy
Pioneering three-year study will investigate technology and workflow needs in a clinical setting.
Wednesday, May 23, 2012
GE Healthcare to acquire Xcellerex Inc.
Addition of high growth company builds integrated, start-to-finish industry offering, focused on lowering costs, increasing productivity and reducing time to market.
Thursday, March 08, 2012
GE Healthcare and Neste Jacobs Form Strategic Alliance
Alliance will help healthcare providers worldwide increase access to life-saving treatments.
Tuesday, January 03, 2012
GE Healthcare and M+W Group Form Strategic Alliance in Vaccines, Insulin and Biopharmaceuticals
Companies to help emerging nations develop their own manufacturing capabilities for essential biopharmaceuticals, reducing reliance on imports.
Wednesday, December 14, 2011
NIBRT and GE Healthcare Announce Biopharmaceutical Research Collaboration
Joint research project to drive new technologies for the development and functional analysis of therapeutic antibodies.
Tuesday, October 04, 2011
GE Healthcare Appoints Kieran Murphy as Life Sciences CEO, Successor to Peter Ehrenheim
On 1 April 2011, Kieran Murphy will be promoted to succeed current Life Sciences President and CEO Peter Ehrenheim who will retire from GE after a transition period on July 31 2011.
Tuesday, February 22, 2011
G-CON Manufacturing and GE Healthcare Announce Intent to Collaborate in Developing Next Generation Modular Bio-therapeutic Manufacturing Technology
G-Con Manufacturing, LLC and GE Healthcare announce their intention to collaborate on the development of a modular portable bio-process manufacturing solution for vaccines and therapeutics.
Friday, December 03, 2010
Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos